Evaluating Biomarkers for Guiding Treatment Decisions. - Wikidata - awgldk - TriplyDB

Evaluating Biomarkers for Guiding Treatment Decisions.

Evaluating Biomarkers for Guiding Treatment Decisions.

http://www.wikidata.org/entity/Q37155171

about

Evaluating Biomarkers for Guiding Treatment Decisions.

http://www.wikidata.org/entity/Q37155171

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 January 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Evaluating Biomarkers for Guiding Treatment Decisions.

@en

Evaluating Biomarkers for Guiding Treatment Decisions.

@nl

type

label

Evaluating Biomarkers for Guiding Treatment Decisions.

@en

Evaluating Biomarkers for Guiding Treatment Decisions.

@nl

prefLabel

Evaluating Biomarkers for Guiding Treatment Decisions.

@en

Evaluating Biomarkers for Guiding Treatment Decisions.

@nl

P1433

Q37155171-02564FA3-C511-422A-9B7A-5078FF676277

P1476

Q37155171-F33A962C-81E5-49ED-A43E-8F5DDFDD9A0A

P2093

Q37155171-45E6669E-7574-46EC-9735-14312981BB2D

Q37155171-9B6B5F79-7263-4AD6-A279-59F07B80494A

P2860

Q37155171-04D6AAF4-7D35-4DB4-9EAD-9A1B418C3294

Q37155171-10D6304B-6BE2-401B-9C98-CE93DA75A7BC

Q37155171-12D0956D-BAC4-4DA5-8BA7-EE2025263FB3

Q37155171-1BAD72EB-C945-4426-AAE4-A04B97D7E6AB

Q37155171-23193FCB-C7E5-4B4D-B475-D75B2B51E40C

Q37155171-24298D3F-F1B3-46E1-A968-85BE6A310EA4

Q37155171-724A4EF7-B9C1-4897-8A1E-24B9D36755D6

Q37155171-76D59C76-D152-460A-892B-475A072ADF70

Q37155171-854D5A03-EC3B-4902-80FE-80A36547E3D1

Q37155171-E42F851D-CEC5-4146-8BDE-54254BA9FEB6

P304

Q37155171-59D3442B-B8AE-4B47-B349-DE6CCE7930B5

P31

Q37155171-41DDBAA5-55FB-4F80-AE6E-CF962FD12D8B

P433

Q37155171-CD7B5419-6A65-4697-94A9-190038536B88

P478

Q37155171-8454C2B3-6586-43AA-B77A-A95FB33BBFF2

P50

Q37155171-899163B4-CB6C-44BC-BBCF-8B8052B626BD

P577

Q37155171-03BE3691-ABFB-4FA8-8BB1-A7FBAF873F5D

P698

Q37155171-5952CC6E-B8CD-4127-9F57-52C4CE9C5138

P921

Q37155171-066547FE-B23D-41F4-84D2-DA5E60DF6C84

P932

Q37155171-43774800-70F1-4E82-95A2-67DDCC79CE3B

P1433

P1476

Evaluating Biomarkers for Guiding Treatment Decisions.

@en

P2093

Patrick M Bossuyt

http://www.w3.org/2001/XMLSchema#string

Tajik Parvin

http://www.w3.org/2001/XMLSchema#string

P2860

Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review

Clinical trial designs for predictive marker validation in cancer treatment trials

Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial.

Measuring the performance of markers for guiding treatment decisions

Characterizing expected benefits of biomarkers in treatment selection.

Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials.

Clinical application of decision analysis: a detailed illustration.

From biomarkers to medical tests: the changing landscape of test evaluation.

Management of late-preterm premature rupture of membranes: the PPROMEXIL-2 trial.

Lung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: what makes it worthwhile?

P304

63-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Patrick Bossuyt

P577

2015-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27683482

http://www.w3.org/2001/XMLSchema#string

P921

P932

4975224

http://www.w3.org/2001/XMLSchema#string